Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
about
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxel.Solute carrier transporters: potential targets for digestive system neoplasms.Comparative untargeted proteomic analysis of ADME proteins and tumor antigens for tumor cell lines.
P2860
Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@ast
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@en
type
label
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@ast
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@en
prefLabel
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@ast
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Characterization of SLC22A18 a ...... iomarker in colorectal cancer.
@en
P2093
Hee-Young Lee
Jaesang Kim
Juhee Keum
Sanghyuk Lee
Suyeon Kim
Yeo Song Lee
Yeonhwa Jung
Yeonjoo Jung
Yong Beom Cho
Yukyung Jun
P2860
P304
25368-25380
P356
10.18632/ONCOTARGET.4681
P407
P577
2015-06-28T00:00:00Z